Immediate Impact
2 hit
Citing Papers
Src kinases as therapeutic targets for cancer
2009 Hit
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Hit
Works of Iain McPherson being referenced
Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors
2005